3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Esophageal Neoplasms
3
Advanced Solid Tumor
3
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Simpson-Golabi-Behmel syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Advanced Solid Tumour
1
Advanced Solid Tumors
1
Advanced Malignancies
1
Adenocarcinoma Of Esophagus
1
Interventions
Radiotherapy
5
Oxaliplatin
5
Nivolumab
5
Fluorouracil
5
Cetuximab
5
Leucovorin
4
Magnetic Resonance Spectroscopy
3
Bevacizumab
3
sintilimab
2
pembrolizumab
2
fludarabine
2
encorafenib
2
aldesleukin
2
Tomography, X-Ray Computed
2
Specimen Handling
2
Pemetrexed
2
Magnetic Resonance Imaging
2
Irinotecan
2
Gemcitabine
2
Folfox protocol
2
Electrocardiography
2
Drug Therapy
2
Dexamethasone
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Biopsy
2
ulixertinib
1
trifluridine tipiracil drug combination
1
trastuzumab biosimilar HLX02
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
tislelizumab
×
30 days
×
Clear all
No trials found.